13 research outputs found
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion
Objectives To test the hypotheses that, compared with conventional outpatient consultations, joint teleconsultation (virtual outreach) would incur no increased costs to the NHS, reduce costs to patients, and reduce absences from work by patients and their carers.Design Cost consequences study alongside randomised controlled trial.Setting Two hospitals in London and Shrewsbury and 29 general practices in inner London and Wales.Participants 3170 patients identified; 2094 eligible for inclusion and willing to participate. 1051 randomised to virtual outreach and 1043 to standard outpatient appointments.Main outcome measures NHS costs, patient costs, health status (SF-12), time spent attending index consultation, patient satisfaction.Results Overall six month costs were greater for the virtual outreach consultations (pound724 per patient) than for conventional outpatient appointments (pound625): difference in means pound99 ($162; is not an element of138) (95% confidence interval pound10 to pound187, P=0.03). if the analysis is restricted to resource items deemed "attributable" to the index consultation, six month costs were still greater for virtual outreach: difference in means pound108 (pound73 to pound142, P < 0.0001). In both analyses the index consultation accounted for the excess cost. Savings to patients in terms of costs and time occurred in both centres: difference in mean total patient cost 8 pound (5 pound to 10 pound, P < 0.0001). Loss of productive time was less in the virtual outreach group: difference in mean cost pound11 (pound10 to pound12, P < 0.0001).Condusion The main hypothesis that virtual outreach would be cost neutral is rejected, but the hypotheses that costs to patients and losses in productivity would be lower are supported
Teleconsultation service to improve healthcare in rural areas: acceptance, organizational impact and appropriateness
Background: Nowadays, new organisational strategies should be indentified to improve primary
care and its link with secondary care in terms of efficacy and timeliness of interventions thus
preventing unnecessary hospital accesses and costs saving for the health system. The purpose of
this study is to assess the effects of the use of teleconsultation by general practitioners in rural
areas.
Methods: General practitioners were provided with a teleconsultation service from 2006 to 2008
to obtain a second opinion for cardiac, dermatological and diabetic problems. Access, acceptance,
organisational impact, effectiveness and economics data were collected. Clinical and access data
were systematically entered in a database while acceptance and organisational data were evaluated
through ad hoc questionnaires.
Results: There were 957 teleconsultation contacts which resulted in access to health care services
for 812 symptomatic patients living in 30 rural communities. Through the teleconsultation service,
48 general practitioners improved the appropriateness of primary care and the integration with
secondary care. In fact, the level of concordance between intentions and consultations for cardiac
problems was equal to 9%, in 86% of the cases the service entailed a saving of resources and in 5%
of the cases, it improved the timeliness. 95% of the GPs considered the overall quality positively.
For a future routine use of this service, trust in specialists, duration and workload of
teleconsultations and reimbursement should be taken into account.
Conclusions: Managerial and policy implications emerged mainly related to the support to GPs in
the provision of high quality primary care and decision-making processes in promoting similar
services
A systematic review of economic analyses of telehealth services using real time video communication
Background: Telehealth is the delivery of health care at a distance, using information and communication technology. The major rationales for its introduction have been to decrease costs, improve efficiency and increase access in health care delivery. This systematic review assesses the economic value of one type of telehealth delivery - synchronous or real time video communication - rather than examining a heterogeneous range of delivery modes as has been the case with previous reviews in this area. Methods A systematic search was undertaken for economic analyses of the clinical use of telehealth, ending in June 2009. Studies with patient outcome data and a non-telehealth comparator were included. Cost analyses, non-comparative studies and those where patient satisfaction was the only health outcome were excluded. Results 36 articles met the inclusion criteria. 22(61%) of the studies found telehealth to be less costly than the non-telehealth alternative, 11(31%) found greater costs and 3 (9%) gave the same or mixed results. 23 of the studies took the perspective of the health services, 12 were societal, and one was from the patient perspective. In three studies of telehealth to rural areas, the health services paid more for telehealth, but due to savings in patient travel, the societal perspective demonstrated cost savings. In regard to health outcomes, 12 (33%) of studies found improved health outcomes, 21 (58%) found outcomes were not significantly different, 2(6%) found that telehealth was less effective, and 1 (3%) found outcomes differed according to patient group. The organisational model of care was more important in determining the value of the service than the clinical discipline, the type of technology, or the date of the study. Conclusion Delivery of health services by real time video communication was cost-effective for home care and access to on-call hospital specialists, showed mixed results for rural service delivery, and was not cost-effective for local delivery of services between hospitals and primary care
Policies and clinical practices relating to the management of gestational diabetes mellitus in the public health sector, South Africa – a qualitative study
BACKGROUND: Women with a prior gestational diabetes have an increased lifetime risk of developing type 2
diabetes. Although post-partum follow-up for GDM women is essential to prevent progression to type 2 diabetes, it
is poorly attended. The need for health systems interventions to support postpartum follow-up for GDM women is
evident, but there is little knowledge of actual current practice. The aim of this study was to explore current policies
and clinical practices relating to antenatal and post-natal care for women with GDM in South Africa, as well as
health sector stakeholders’ perspectives on the barriers to – and opportunities for – delivering an integrated
mother - baby health service that extends beyond the first week post-partum, to the infant’s first year of life.
METHODS: Following a document review of policy and clinical practice guidelines, in-depth interviews were
conducted with 11 key informants who were key policy makers, health service managers and clinicians working in
the public health services in South Africa’s two major cities (Johannesburg and Cape Town). Data were analysed
using qualitative content analysis procedures.
RESULTS: The document review and interviews established that it is policy that health services adhere to
international guidelines for GDM diagnosis and management, in addition to locally developed guidelines and
protocols for clinical practice. All key informants confirmed that lack of postpartum follow-up for GDM women is a
significant problem. Health systems barriers include fragmentation of care and the absence of standardised
postnatal care for post-GDM women. Key informants also raised patient - related challenges including lack of
perceived future risk of developing type 2 diabetes and non-attendance for postpartum follow up, as barriers to
postnatal care for GDM women. All participants supported integrated primary health services but cautioned against
overloading health workers.
CONCLUSION: Although there is alignment between international guidelines, local policy and reported clinical
practice in the management of GDM, there is a gap in continuation of care in the postpartum period. Health
systems interventions that support and facilitate active follow-up for women with prior GDM are needed if high
rates of progression to type 2 diabetes are to be avoided
A cost effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
Objectives To compare the cost-effectiveness (CE) of the National Institute for Health and Care Excellence (NICE) 2015 and the WHO 2013 diagnostic thresholds for gestational diabetes mellitus (GDM). Setting The analysis was from the perspective of the National Health Service in England and Wales. Participants 6221 patients from four of the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study centres (two UK, two Australian), 6308 patients from the Atlantic Diabetes in Pregnancy study and 12 755 patients from UK clinical practice. Primary and secondary outcome measures planned The incremental cost per quality-adjusted life year (QALY), net monetary benefit (NMB) and the probability of being cost-effective at CE thresholds of £20 000 and £30 000 per QALY. Results In a population of pregnant women from the four HAPO study centres and using NICE-defined risk factors for GDM, diagnosing GDM using NICE 2015 criteria had an NMB of £239 902 (relative to no treatment) at a CE threshold of £30 000 per QALY compared with WHO 2013 criteria, which had an NMB of £186 675. NICE 2015 criteria had a 51.5% probability of being cost-effective compared with the WHO 2013 diagnostic criteria, which had a 27.6% probability of being cost-effective (no treatment had a 21.0% probability of being cost-effective). For women without NICE risk factors in this population, the NMBs for NICE 2015 and WHO 2013 criteria were both negative relative to no treatment and no treatment had a 78.1% probability of being cost-effective. Conclusion The NICE 2015 diagnostic criteria for GDM can be considered cost-effective relative to the WHO 2013 alternative at a CE threshold of £30 000 per QALY. Universal screening for GDM was not found to be cost-effective relative to screening based on NICE risk factors
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion
Objectives To test the hypotheses that, compared with conventional outpatient consultations, joint teleconsultation (virtual outreach) would incur no increased costs to the NHS, reduce costs to patients, and reduce absences from work by patients and their carers. Design Cost consequences study alongside randomised controlled trial. Setting Two hospitals in London and Shrewsbury and 29 general practices in inner London and Wales. Participants 3170 patients identified; 2094 eligible for inclusion and willing to participate. 1051 randomised to virtual outreach and 1043 to standard outpatient appointments. Main outcome measures NHS costs, patient costs, health status (SF-12), time spent attending index consultation, patient satisfaction. Results Overall six months costs were greater for the virtual outreach consultations (£724 per patient) than for conventional outpatient appointments (£625): difference in means £99 ($162; €138) (95% confidence interval £10 to £187, P=0.03). If the analysis is restricted to resource items deemed “attributable” to the index consultation, six month costs were still greater for virtual outreach: difference in means £108 (£73 to £142, P < 0.0001). In both analyses the index consultation accounted for the excess cost. Savings to patients in terms of costs and time occurred in both centres: difference in mean total patient cost £8 (£5 to £10, P < 0.0001). Loss of productive time was less in the virtual outreach group: difference in mean cost £11 (£10 to £12, P < 0.0001). Conclusion The main hypothesis that virtual outreach would be cost neutral is rejected, but the hypotheses that costs to patients and losses in productivity would be lower are supported